Items Tagged ‘clinical trials’
February 5, 2019
Research News Roundup-January 2019
The Mayo Clinic Research News Roundup includes brief summaries and links to research-related news releases from Mayo Clinic in the past month. It also connects readers to associated resources. Read on for more information from Mayo Clinic Research. Minnesota Partnership awards 5 collaborative research grants Diabetes, stress-induced aging and Alzheimer’s disease, immigration-related obesity, and implantable drug […]
Tags: artificial intelligence, basic science, biomarkers, cancer, cervical cancer, clinical trials, concussion, heart failure, James Kirkland, Kathy MacLaughlin, Kogod Center on Aging, Mayo Clinic Proceedings
February 4, 2019
“Only” a medical student, already advancing the science
By Jon Holten 
Rosalie Sterner is already impressive, concurrently pursuing her M.D. and Ph.D. degrees through Mayo Clinic College of Medicine and Science. However, recently she made additional waves, as the lone medical student to receive the 2018 Outstanding Abstract Achievement Award from the American Society of Hematology. Sterner received this award and presented her work on development […]
Tags: CAR-T, clinical trials, hematology, immunology, Karen Hedin, lymphoma, Rosalie Sterner, Saad Kenderian
January 2, 2019
Toward clinical trials for one type of ALS
By Kate Ledger 
When a team of Mayo Clinic researchers discovered in 2011 the genetic repeat mutation known as c9orf72, the finding shed new light on amyotrophic lateral sclerosis (ALS). The mutation, which occurs as a short sequence of code repeated hundreds to thousands of times in the gene, is now known to appear in 40 percent of […]
Tags: ALS, amyotrophic lateral sclerosis, Björn Oskarsson, clinical trials, Dennis Dickson, Kevin Boylan, Leonard Petrucelli, Lou Gehrig's disease, neurology, neurosciences, Rosa Rademakers, Tania Gendron
December 13, 2018
By Advancing the Science contributor
In 2011, Jared Ausnehmer left his local hospital carrying the weight of an oxygen tank and the worry of what might come next. At age 21, he’d already defied the odds for those born with hypoplastic left heart syndrome, a birth defect in which the left side of the heart is underdeveloped or nonexistent. With […]
Tags: Andre Terzic, cardiology, Center for Regenerative Medicine, clinical trials, HLHS, hypoplastic left heart syndrome
November 5, 2018
Early-phase Cancer Clinical Trials (Phase I) Available at Mayo Clinic
The Early Cancer Therapeutics Group at Mayo Clinic offers patients whose cancers haven’t responded to standard chemotherapy or other treatments the opportunity to join an early-phase clinical trial of a potential new treatment. Early-phase clinical trials (phase I) determine safe dosage levels and safe methods of treatment delivery. A phase I clinical trial might be […]
September 11, 2018
Meet Katrina Croghan, Clinical Research Coordinator
By Advancing the Science contributor
Katrina Croghan is clinical research coordinator for Mayo Clinic Cancer Center, assigned to the division of Hematology in Rochester, Minnesota. She began her career in ecology and animal science, but while en route to a related Ph.D., ended up as a supplemental research coordinator because of her knowledge of writing protocols and conducting research. She says: “For a short […]
Tags: clinical trials, hematology, Katrina Croghan, Mayo Clinic Cancer Center
August 6, 2018
Regenerative medicine in novel fetal therapy program
A life-saving procedure improves fetal lung health and reduces post-natal complications Specialists at Mayo Clinic are pioneering a life-saving procedure as part of a clinical trial for babies with congenital diaphragmatic hernia (CDH). When a baby’s lungs are not adequately developed at birth, severe complications and even death can result. Waiting for the baby to be […]
Tags: Center for Regenerative Medicine, clinical trials, Denise Klinker, maternal and fetal medicine, Mayo Clinic Proceedings, minimally invasive surgery, regenerative medicine, Regenerative Medicine Minnesota, Rodrigo Ruano
July 25, 2018
Advances in lung cancer immunotherapy and management of immune-mediated adverse events
By Advancing the Science contributor
Over the last few years, immunotherapy using immune checkpoint inhibitors targeting programmed cell death receptor 1 (PD-1) or programmed cell death receptor ligand 1 (PD-L1) has revolutionized the therapeutic approach to advanced-stage non-small cell lung cancer and numerous other malignancies. Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for […]
Tags: clinical trials, immunotherapy, lung cancer, Mayo Clinic Cancer Center, measles virus
July 9, 2018
Offering underserved groups access to cutting-edge research
For many patients, clinical trials offer a chance to benefit from promising new treatments that are not available in the doctor’s office. Yet not all people have the same access to these opportunities. Groups such as racial minorities, older individuals, and those with low income are less likely than others to participate in clinical trials, […]
Tags: biobank, blood cancer, Carmen Radecki Breitkopf, clinical trials, community engagement, Gerardo Colon-Otero, health disparities, hematology, HPV, lymphoma, Mayo Clinic Cancer Center
June 14, 2018
Bridging the gap: Introducing the health care of tomorrow
Forward-thinking leadership, unparalleled expertise and a commitment to solving unmet patient needs allow Mayo Clinic to bridge the gap between the delivery of traditional health care today and the rapid advancement of revolutionary care in the near future. Increasing Translational Capabilities Traditionally, it could take years for physician-scientists to develop the essential expertise to create […]
Tags: Center for Regenerative Medicine, clinical trials, Mayo Clinic Graduate School of Biomedical Sciences, regenerative medicine, research education, stem cells